Insights

Gathering insights about UCAN…

Similar companies to UCAN

UCAN Tech Stack

UCAN uses 8 technology products and services including jQuery CDN, Shopify, Vue.js, and more. Explore UCAN's tech stack below.

jQuery CDN
Content Delivery Network
Shopify
E-commerce
Vue.js
Javascript Frameworks
Polyfill
Javascript Libraries
Envoy
Load Balancers
Tailwind CSS
UI Frameworks
Accentuate Custom Fields
Web Platform Extensions
AddShoppers
Widgets

Media & News

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings
Dec 10, 2025 | www.globenewswire.com
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued Listing Criteria Well Capitalized with Anticipated Cash Runway into 2029 EDINBURGH, United Kingdom, Nov. 13, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced financial results for the third quarter ended September 30, 2025 and provided an update on its clinical development program with its two lead anti-cancer medicines. “We recently announced promising data for both NUC-7738 and NUC-3373 that continue to support the potential of our ProTides to deliver significantly improved treatment outcomes for patients with cancer,” said Hugh S.
Nov 13, 2025 | www.globenewswire.com
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
EDINBURGH, United Kingdom, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced that the China National Intellectual Property Administration (“CNIPA”) has granted an important patent covering the composition of matter for NUC-7738. This patent (ZL 202010794701.2) is expected to serve as a key component of the patent protection for NUC-7738, which currently consists of over 85 issued patents worldwide. The composition of matter patent covers the chemical structure of NUC-7738, NuCana's novel anti-cancer agent currently being evaluated in a Phase 1/2 clinical study (NuTide:701) in combination with pembrolizumab for patients with PD-1 inhibitor refractory or resistant melanoma. Securing this patent represents an important milestone for NuCana, strengthening its long-term global intellectual property strategy, while supporting potential opportunities to address unmet needs for innovative cancer therapies in China.
Nov 05, 2025 | www.globenewswire.com
NuCana Compliant with All Nasdaq Continued Listing Criteria
EDINBURGH, United Kingdom, Sept. 05, 2025 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced that it has received formal notification from The Nasdaq Stock Market on September 4, 2025 confirming that the Company is in compliance with all applicable Nasdaq continued listing criteria, including the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Sep 05, 2025 | www.globenewswire.com
NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025
EDINBURGH, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced a presentation at the upcoming annual European Society for Medical Oncology (“ESMO”) congress being held October 17-21, 2025 in Berlin, Germany (the “ESMO Congress 2025”).
Sep 03, 2025 | www.globenewswire.com
NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
First Patients Dosed on Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma
Aug 20, 2025 | www.globenewswire.com
NuCana Announces ADS Ratio Change
EDINBURGH, United Kingdom, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces that it will implement the Company's previously disclosed plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing twenty-five (25) ordinary shares, to one (1) ADS representing five thousand (5,000) ordinary shares (the "ADS Ratio"). The change in the ADS Ratio is expected to become effective on August 11, 2025 (the "Effective Date").
Aug 01, 2025 | www.globenewswire.com

UCAN's Email Address Formats

UCAN uses at least 2 format(s):

UCAN Email Formats	Example	Percentage
First.Last@generationucan.com	John.Doe@generationucan.com	100%
First.Last@ucan.co	John.Doe@ucan.co	50%
Last@ucan.co	Doe@ucan.co	50%

Frequently Asked Questions

Where is UCAN's headquarters located?

UCAN's main headquarters is located at 11 Research Drive, #1. The company has employees across 4 continents, including North AmericaAfricaEurope.

What is UCAN's stock symbol?

UCAN is a publicly traded company; the company's stock symbol is NCNA.

What is UCAN's official website and social media links?

UCAN's official website is ucan.co and has social profiles on LinkedIn Crunchbase.

What is UCAN's NAICS code?

UCAN's NAICS code is 71394 - Fitness and Recreational Sports Centers.

How many employees does UCAN have currently?

As of December 2025, UCAN has approximately 185 employees across 4 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer And Board Director: E. S.Vice President Of Finance: J. H.Founder, Cio (chief Inspiration Officer): P. B.. Explore UCAN's employee directory with LeadIQ.

What industry does UCAN belong to?

UCAN operates in the Wellness and Fitness Services industry.

What technology does UCAN use?

UCAN's tech stack includes jQuery CDNShopifyVue.jsPolyfillEnvoyTailwind CSSAccentuate Custom FieldsAddShoppers.

What is UCAN's email format?

UCAN's email format typically follows the pattern of First.Last@generationucan.com. Find more UCAN email formats with LeadIQ.

How much funding has UCAN raised to date?

As of December 2025, UCAN has raised $11M in funding. The last funding round occurred on Mar 23, 2023 for $11M.

When was UCAN founded?

UCAN was founded in 2010.

UCAN

Q: What is UCAN's official website and social media links?

UCAN's official website is ucan.co. UCAN has social profiles on LinkedIn.

Q: How many employees does UCAN have currently?

UCAN has approximately 185 employees.

Q: What technology does UCAN use?

UCAN's tech stack includes X-Content-Type-Options, oEmbed, Tailwind CSS, Unpkg, GoAffPro.

Wellness and Fitness ServicesConnecticut, United States51-200 Employees

UCAN is empowering the greatest athletes in the world to achieve their next personal best. Using the revolutionary energy provided by LIVSTEADY - a slow-release carbohydrate that gives you steady, long-lasting energy without sugar, UCAN provides the fuel for athletes to take their performance to the next level. Whatever your goals, be it focus, performance, or recovery you can unlock next-level performance with UCAN.

Company Overview

Headquarters: 11 Research Drive, #1
Website: ucan.co
Stock Symbol: NCNA
NAICS Code: 71394 - Fitness and Recreational Sports Centers
Founded: 2010
Employees: 51-200

Media & News

Funding & Financials

$11M
UCAN has raised a total of $11M of funding over 5 rounds. Their latest funding round was raised on Mar 23, 2023 in the amount of $11M.
$1M$10M
UCAN's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$11M
UCAN has raised a total of $11M of funding over 5 rounds. Their latest funding round was raised on Mar 23, 2023 in the amount of $11M.
$1M$10M
UCAN's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to UCAN

Onward Neighborhood House

Rush University Medical Center

Erie Neighborhood House

Park Center

CAP

Centers for New Horizons

Association House of Chicago

The Kennedy Forum

Clarity Clinic

UCAN Tech Stack

Media & News

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China

NuCana Compliant with All Nasdaq Continued Listing Criteria

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

NuCana Announces ADS Ratio Change

UCAN's Email Address Formats

Frequently Asked Questions

Where is UCAN's headquarters located?

What is UCAN's stock symbol?

What is UCAN's official website and social media links?

What is UCAN's NAICS code?

How many employees does UCAN have currently?

What industry does UCAN belong to?

What technology does UCAN use?

What is UCAN's email format?

How much funding has UCAN raised to date?

When was UCAN founded?

UCAN

Company Overview

Media & News

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?